Anafranil: Restoring Balance in Severe OCD Treatment
Anafranil
| Product dosage: 25mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.88 | $53.00 (0%) | 🛒 Add to cart |
| 90 | $0.80 | $79.50 $72.00 (9%) | 🛒 Add to cart |
| 120 | $0.76 | $106.00 $91.00 (14%) | 🛒 Add to cart |
| 180 | $0.72 | $159.00 $129.00 (19%) | 🛒 Add to cart |
| 270 | $0.69 | $238.50 $185.00 (22%) | 🛒 Add to cart |
| 360 | $0.67
Best per pill | $318.00 $242.00 (24%) | 🛒 Add to cart |
| Product dosage: 50mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.87 | $56.00 (0%) | 🛒 Add to cart |
| 60 | $1.47 | $112.00 $88.00 (21%) | 🛒 Add to cart |
| 90 | $1.34 | $168.00 $121.00 (28%) | 🛒 Add to cart |
| 120 | $1.27 | $224.00 $153.00 (32%) | 🛒 Add to cart |
| 180 | $1.22 | $336.00 $219.00 (35%) | 🛒 Add to cart |
| 270 | $1.17 | $504.00 $315.00 (38%) | 🛒 Add to cart |
| 360 | $1.15
Best per pill | $672.00 $413.00 (39%) | 🛒 Add to cart |
| Product dosage: 75mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $2.60 | $78.00 (0%) | 🛒 Add to cart |
| 60 | $2.08 | $156.00 $125.00 (20%) | 🛒 Add to cart |
| 90 | $1.91 | $234.00 $172.00 (26%) | 🛒 Add to cart |
| 120 | $1.83 | $312.00 $220.00 (29%) | 🛒 Add to cart |
| 180 | $1.75 | $468.00 $315.00 (33%) | 🛒 Add to cart |
| 270 | $1.69
Best per pill | $702.00 $457.00 (35%) | 🛒 Add to cart |
Synonyms | |||
Anafranil (clomipramine hydrochloride) is a tricyclic antidepressant (TCA) with potent serotonin reuptake inhibition properties, approved for the treatment of obsessions and compulsions in patients with obsessive-compulsive disorder (OCD). It represents one of the most rigorously studied pharmacologic interventions for moderate to severe OCD, demonstrating significant efficacy in reducing symptom severity and improving functional outcomes. Its mechanism centers on enhancing serotonergic neurotransmission, which is critically implicated in the pathophysiology of OCD. Clinicians often consider it a foundational agent when first-line SSRIs prove inadequate or intolerable.
Features
- Active ingredient: Clomipramine hydrochloride
- Available formulations: 10 mg, 25 mg, 50 mg capsules
- Pharmacologic class: Tricyclic antidepressant (TCA)
- Primary mechanism: Potent inhibition of serotonin reuptake; also inhibits norepinephrine reuptake
- Half-life: Approximately 19–37 hours for clomipramine; active metabolite desmethylclomipramine has a half-life of 54–77 hours
- Bioavailability: >50% following oral administration
- Metabolism: Hepatic, primarily via CYP450 enzymes (CYP2D6, CYP2C19, CYP3A4)
Benefits
- Significantly reduces the frequency and intensity of obsessive thoughts and compulsive behaviors.
- Improves overall psychosocial functioning and quality of life in patients with severe OCD.
- Provides an alternative for patients who have not responded adequately to SSRIs.
- Long half-life supports once-daily dosing in maintenance phase, enhancing adherence.
- Evidence-supported efficacy in both acute and long-term management of OCD.
- May also benefit comorbid conditions such as major depression and panic disorder.
Common use
Anafranil is primarily indicated for the treatment of obsessions and compulsions in patients diagnosed with obsessive-compulsive disorder. It is used when the condition causes marked distress, is time-consuming, or significantly interferes with social, occupational, or other important areas of functioning. It may also be used off-label under specialist supervision for conditions such as panic disorder, severe depression, chronic pain syndromes, and cataplexy associated with narcolepsy. Treatment should always be initiated under the supervision of a healthcare provider experienced in the use of psychotropic medications.
Dosage and direction
Dosage must be individualized based on patient response and tolerance. For adults with OCD, treatment typically begins with 25 mg daily, gradually increased to 100 mg during the first two weeks. After this, dosage may be further increased to a maximum of 250 mg per day, as tolerated. Daily doses above 150 mg should preferably be divided and taken with meals to minimize gastrointestinal side effects. For elderly patients or those with hepatic impairment, lower initial doses and slower titration are advised. Regular monitoring of clinical response and side effects is essential. Maintenance treatment should continue at the lowest effective dose.
Precautions
Patients should be monitored for worsening depression, suicidality, or unusual changes in behavior, especially during initial treatment or dose adjustments. Anafranil may cause sedation; patients should avoid driving or operating machinery until they know how the medication affects them. Caution is advised in patients with cardiovascular disease, history of seizures, glaucoma, urinary retention, or hyperthyroidism. Regular monitoring of blood pressure, heart rate, and ECG may be necessary in susceptible individuals. Abrupt discontinuation should be avoided due to risk of withdrawal symptoms.
Contraindications
Anafranil is contraindicated in patients with known hypersensitivity to clomipramine or other tricyclic antidepressants. It should not be used concomitantly with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy due to risk of serotonin syndrome. It is also contraindicated during the acute recovery phase after myocardial infarction and in patients with severe liver impairment.
Possible side effect
Common side effects include dry mouth, constipation, blurred vision, drowsiness, dizziness, weight gain, increased sweating, and orthostatic hypotension. Sexual dysfunction, such as decreased libido or delayed ejaculation, may occur. Less frequently, patients may experience tachycardia, ECG changes, tremors, or confusion. Serious but rare adverse effects include seizures, agranulocytosis, and neuroleptic malignant syndrome. Any unusual or severe symptoms should be reported to a healthcare provider immediately.
Drug interaction
Anafranil has a significant potential for drug interactions. Concomitant use with SSRIs, SNRIs, triptans, or other serotonergic drugs increases the risk of serotonin syndrome. It may potentiate the effects of CNS depressants such as alcohol, benzodiazepines, and opioids. CYP2D6 inhibitors (e.g., fluoxetine, paroxetine) can increase clomipramine levels. Use with anticholinergic agents may exacerbate side effects. Anafranil may reduce the antihypertensive effect of guanethidine and similar agents.
Missed dose
If a dose is missed, it should be taken as soon as remembered unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended.
Overdose
Anafranil overdose can be severe and potentially fatal. Symptoms may include severe drowsiness, agitation, confusion, tachycardia, hypotension, seizures, coma, and cardiac arrhythmias. Management involves immediate medical attention, gastric lavage if presented early, activated charcoal, and supportive measures including ECG monitoring and treatment of symptoms. There is no specific antidote.
Storage
Store at room temperature (15–30°C or 59–86°F) in a tightly closed container, away from light, moisture, and heat. Keep out of reach of children and pets. Do not use after the expiration date printed on the packaging.
Disclaimer
This information is intended for educational purposes and does not replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting or changing any medication regimen. Individual patient needs and responses may vary.
Reviews
Clinical studies and meta-analyses consistently support the efficacy of Anafranil in reducing OCD symptoms, with response rates often exceeding those of placebo and comparable to SSRIs. Many patients report substantial improvement in quality of life after several weeks of treatment. However, side effects such as weight gain and sedation are frequently noted. Specialist supervision is emphasized to balance benefits against adverse effects.